A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90Yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: Preliminary results on toxicity and response rates

In Vivo

Volumn 20, Issue 6 A, 2006, Pages 711-714

  Mancini, R ^a   Carpanese, L ^a   Sciuto, R ^a   Pizzi, G ^a   Golfieri, R ^b   Giampalma, L ^b   Cappelli, A ^b   Galaverni, M C ^b   Blotta, A ^b   Fiore, F ^c   Izzo, F ^c   Lastoria, S ^c   Mastro, A ^c   Di Marzo, M ^c   Cagol, P P ^d   Gasparini, D ^d   Geatti, O ^d   Bacchetti, S ^d   Pasqual, E ^d   Zeuli, M ^a   Paoletti, G ^a   Garufi, C ^a   Cosimelli, Maurizio ^a   more..

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF UDINE   (Italy)

Author keywords

Colorectal liver metastases; Locoregional therapies; SIRT

Indexed keywords

IRINOTECAN; MICROSPHERE; OXALIPLATIN; RESIN; YTTRIUM 90;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD ANALYSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELIAC ANGIOGRAPHY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEVER; FOLLOW UP; FREQUENCY ANALYSIS; GASTRODUODENAL ARTERY; HEPATIC ARTERY; HUMAN; INOPERABLE CANCER; JAUNDICE; LEUKOCYTOSIS; LIVER ANGIOGRAPHY; LIVER METASTASIS; LUNG ARTERIOVENOUS SHUNT; MORTALITY; MULTICENTER STUDY; NAUSEA; PAIN; PHASE 2 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; QUALITY OF LIFE; SAFETY; SIDE EFFECT; SUPERIOR MESENTERIC ANGIOGRAPHY; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 33846095507     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Gafoor A, sFever EJ and Thun MJ: Cancer Statistics. 2005. CA Cancer J Clin 55: 10-30, 2005.
2. Landis SH, Murray T, Bolden S and Wingo PA: Cancer Statistic, 1999. CA Cancer J Clin 49: 8-31, 1999.
3. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA and Strasberg SM: Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240: 438-447, 2004.
4. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Ragsin R, Schulic RD, Lillemoe KD, Yeo CL and Cameron JL: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235: 759-766, 2002.
5. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L and Vauthey JN: Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241: 715-722, 2005.
6. Nagorney DM and Gigot JF: Primary epithelial hepatic malignancies: etiology, epidemiology, and outcome after subtotal and total hepatic resection. Surg Oncol Clin N Am 5: 283-300, 1996.
7. Chua YJ and Cunningham D: Neoadjuvant treatment of unresectable liver metastases from colorectal cancer. Clin Colorectal Cancer 5(6): 405-412, 2006.
8. Gray BN, Anderson JE, Burton MA, van Hazel G, Codde J, Morgan C and Klemp P: Regression of liver metastases following treatment with yttrium 90 microspheres. Aust N Z J Surg 62: 105-110, 1992.
9. Stubbs RS, Cannan RJ and Mitchell AW: Selective internal radiation therapy (SIRT) with yttrium 90 microspheres for extensive colorectal liver metastases. Hepatogastroenterology 48: 333-337, 2001.
10. Lau WY, Leung WT, Ho S, Leung NW, Chan M, Lin J, Metreweli C, Johnson P and Li AK: Treatment for inoperable hepatocellular carcinoma with intrahepatic arterial yttrium 90 microspheres: a phase I and II study. Br J Cancer 70: 994-999, 1994.
11. 90yttrium microspheres. Int J Radiat Oncol Biol Phys 40: 583-592, 1998.
12. Coldwell D, Kenedy AS and Van Echo DA: Feasibility of treatment of hepatic tumors utilizing with yttrium 90 glass microspheres. J Vasc Interv Radiol 12: s113, 2001.
13. Kennedy AS, Murthy R, Sarfaz M et al: Outpatient hepatic artery brachytherapy for primary and secondary hepatic malignancies. Radiology 221P: 468, 2001.
14. Kennedy AS, Murthy R, Van Echo DA et al: Preliminary results of outpatient hepatic artery brachytherapy for colorectal hepatic metastases. European Journal of Cancer 37: 289, 2001.
15. Murthy R, Kennedy AS, Coldwell D et al: Technical aspects of Theraspheres (TS) infusion. J Vasc Interv Radiol 13: s2, 2002.
16. Van Echo DA, Kennedy AS and Coldwell D: Theraspheres (TS) at 143 Gy median dose for mixed hepatic cancers; feasibility and toxicities. Amer Soc Clin Oncol 260a: 1038, 2001.
17. Gray B, Van Hazel G, Buck M et al: Treatment of colorectal liver metastases with SIR-spheres plus chemotherapy. GI Cancer 3(4): 249-257, 2000.
18. Gray B, Van Hazel G, Hope M, Burton M, Moroz P, Anderson J and Gebski V: Randomized trial of SIR-Spheres plus chemotherapy versus chemotherapy alone for treating patients with liver metastases for primary large bowel cancer. Ann Oncol 12: 1711-1720, 2001.
19. Van Hazel G, Blackwell A, Anderson J et al: Randomized phase II trial on SIR. Spheres plus Fluorouracil/leucovorin chemotherapy versus Fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. Proceedings of ASCO, 2002.
20. Kennedy AS, Coldwell D, Nutting G, Murthy R, Wertman DE Jr, Loehr SP, Overton C, Meranze S, Niedzwiecki J and Sailer S: Resin 90Y-microspheres brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 65(2): 412, 2006.
21. Aigner KR: Intra-arterial infusion: overview and novel approaches. Sem Surg Oncol 14(3): 248-253, 1998.
22. Steel J, Baum A and Carr B: Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of cisplatin vs. 90-yttrium microspheres (theraspheres), Psychooncology 13(2): 73-79, 2004.